EXHIBIT 99.1

PETMED  EXPRESS D/B/A 1-800-PETMEDS ANNOUNCES $20  MILLION  SHARE
REPURCHASE PROGRAM

Pompano Beach, Florida, November 8, 2006 - The Board of Directors
of  PetMed  Express,  Inc. (NASDAQ:PETS)  has  approved  a  share
repurchase  program of up to $20 million, effective  immediately.
This program is intended to be implemented through purchases made
from  time  to time in either the open market or through  private
transactions  at  the  Company's discretion,  subject  to  market
conditions  and other factors, in accordance with Securities  and
Exchange Commission requirements.  As of November 8, 2006, PetMed
Express, Inc. has 24.2 million shares outstanding.

"The  authorization  from the Board to repurchase  shares  is  an
indication  of our Company's financial strength and  demonstrates
the confidence we have in our Company," commented Menderes Akdag,
CEO and President of PetMed Express, Inc.  "The cash productivity
of our business model enables us to actively invest cash in areas
that  we believe will drive future value for shareholders.   This
share  repurchase plan demonstrates our continued  commitment  to
deliver long-term shareholder value."

Founded  in  1996,  PetMed  Express  is  America's  Largest   Pet
Pharmacy,   delivering  prescription  and  non-prescription   pet
medications and other health products for dogs, cats, and  horses
at  competitive prices direct to the consumer through its  1-800-
PetMeds  toll free number and on the Internet through its website
at www.1800petmeds.com.
   -------------------

This  press release may contain "forward-looking" statements,  as
defined  in the Private Securities Litigation Reform Act of  1995
or  by  the  Securities and Exchange Commission, that  involve  a
number  of  risks  and  uncertainties,  including  the  Company's
ability  to  meet the objectives included in its  business  plan.
Important  factors that could cause results to differ  materially
from those indicated by such "forward-looking" statements are set
forth  in  Management's  Discussion  and  Analysis  of  Financial
Condition  and Results of Operation in the PetMed Express  Annual
Report  on  Form  10-K for the year ended March  31,  2006.   The
Company's  future  results may also be  impacted  by  other  risk
factors  listed from time to time in its SEC filings,  including,
but not limited to, the Company's Form 10-Q and its Annual Report
on Form 10-K.

For  investment relations contact PetMed Express, Inc., Bruce  S.
Rosenbloom, CFO, 954-979-5995.

                               ###
                     Exhibit 99.1 Page 1 - 1